There ’s Only Weak Evidence For Vitamin-D As a COVID-19 Preventative—But Scientists Are Trying to Learn More
To protect himself from COVID-19, Dr. Anthony Fauci has long said he’s skipping hugs and handshakes, wearing a mask, and staying off of planes. Last week, he acknowledged adding another step to protect his health: taking supplements of vitamin-D. “If you are deficient in Vitamin-D, that does have an impact on your susceptibility to infection,” Fauci, head of the National Institute of Allergy and Infectious Diseases, said in an interview posted on Instagram last week. “So I would not mind recommending—and I do it myself—taking vitamin-D supplements.” However, while spurious claims t...
Source: TIME: Health - September 17, 2020 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news

Eli Lilly Claims Experimental Drug Protects Covid-19 Patients
A so-called monoclonal antibody lowered levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts. (Source: NYT Health)
Source: NYT Health - September 17, 2020 Category: Consumer Health News Authors: Gina Kolata Tags: Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Antibodies Clinical Trials Eli Lilly and Company National Institutes of Health United States Source Type: news

NIH funds research into differences in glioblastoma between males and females
(Cleveland Clinic) A team led by researchers from Case Western Reserve University School of Medicine and Cleveland Clinic Lerner Research Institute has secured $10.4 million over five years from the National Institutes of Health/National Cancer Institute to explore at the molecular level the differences in glioblastoma between males and females. The researchers will delve into the genetics, epigenetics and cell biology of glioblastoma - the most common and deadliest brain tumor in adults - to better understand the physiologic processes which may lead to more personalized therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 17, 2020 Category: Cancer & Oncology Source Type: news

Shafiee Awarded NIH SBIR Fast-Track Phase II Grant
Hadi Shafiee, PhD, of the Division of Engineering in Medicine, received a Fast-Track Phase II grant from the National Institutes of Health ‘s Small Business Innovation Research program (NIH SBIR). This award grants funds to small businesses that promi (Source: BWH News)
Source: BWH News - September 17, 2020 Category: Hospital Management Source Type: news

NIH funds community engagement research efforts in areas hardest hit by COVID-19
Outreach will focus on COVID-19 awareness and education research, especially among African Americans, Hispanics/Latinos, and American Indians. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 16, 2020 Category: American Health Source Type: news

Ely Lilly Claims Experimental Drug Protects Covid-19 Patients
A so-called monoclonal antibody lowered blood levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts. (Source: NYT Health)
Source: NYT Health - September 16, 2020 Category: Consumer Health News Authors: Gina Kolata Tags: Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Antibodies Clinical Trials Eli Lilly and Company National Institutes of Health United States Source Type: news

Sanford Burnham Prebys receives $3M NIH award for drugs that restore immune response to COVID-19
(Sanford Burnham Prebys Medical Discovery Institute) Scientists at Sanford Burnham Prebys Medical Discovery Institute have received a $3 million grant from the National Institutes of Health (NIH) to study how SARS-CoV-19 weakens the immune system -- and identify drugs to help infected individuals recover. The research will be led by Carl Ware, Ph.D., director of the Institute's Infectious and Inflammatory Disease Center, and builds on the Institute-wide initiative to develop therapeutics to treat COVID-19. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 16, 2020 Category: Biology Source Type: news

Where trouble starts
(University of Delaware) In the earliest hours of your embryonic status, cells were developing and multiplying, critical processes were starting up, networks were connecting and genetic codes -- for better or worse -- were directing the whole project.That early development is the focus of University of Delaware biologist Shuo Wei's research. Wei looks specifically at how problems in cellular signal relays affect these processes and cause birth defects and now his research has won more than $1.8 million in support from the National Institutes of Health. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 16, 2020 Category: Biology Source Type: news

Top San Diego research institutions, led by Salk, to receive an expected $5 million to study aging
(Salk Institute) The Salk Institute will establish a world-class San Diego Nathan Shock Center (SD-NSC), a consortium with Sanford Burnham Prebys Medical Discovery Institute and the University of California San Diego (UC San Diego), to study cellular and tissue aging in humans. The Center will be funded by a grant from the National Institute on Aging (NIA) of the National Institutes of Health expected to total $5 million over the next 5 years (NIA grant number P30AG068635). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 16, 2020 Category: International Medicine & Public Health Source Type: news

NIH awards contracts to develop innovative digital health technologies for COVID-19
The projects represent a broad range of solutions for immediate public health needs related to the pandemic. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 15, 2020 Category: American Health Source Type: news

Vaping, marijuana use in 2019 rose in college-age adults
Increases are among the largest in history of national study. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 15, 2020 Category: American Health Source Type: news

NIH 'very concerned' about serious side effect in AstraZeneca coronavirus vaccine trial
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case. (Source: CNN.com - Health)
Source: CNN.com - Health - September 15, 2020 Category: Consumer Health News Source Type: news

NIH public-private partnership to advance early interventions for schizophrenia
Effort is part of the Accelerating Medicines Partnership to promote development of effective, targeted treatments. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 15, 2020 Category: American Health Source Type: news

NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19
(NIH/National Cancer Institute) The National Institutes of Health has awarded seven contracts to companies and academic institutions to develop digital health solutions that help address the COVID-19 pandemic. The work could lead to user-friendly tools like smartphone apps, wearable devices, and software that can identify and trace contacts of infected individuals, keep track of verified COVID-19 test results, and monitor the health status of infected and potentially infected individuals. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 15, 2020 Category: Infectious Diseases Source Type: news

Hopelessness in heart patients study to factor in COVID-19
(University of Illinois at Chicago) A University of Illinois Chicago research study on how to improve care for heart disease patients struggling with hopelessness has been supplemented by the National Institutes of Health, or NIH, to determine whether the study intervention called " Heart Up! " limits the negative impact of COVID-19 shelter-in-place and physical distancing measures on health outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 15, 2020 Category: International Medicine & Public Health Source Type: news

Science, Medical Groups Oppose Fetal Tissue Ethics Board Recommendations
AIBS joined 76 other scientific, medical, and patient groups in expressing concerns about the National Institutes of Health (NIH) Human Fetal Tissue Ethics Advisory Board’s report that recommends withholding funding for most of the applications submitted to NIH to conduct medical research using human fetal tissue. After reviewing 14 research proposals in July 2020, the Ethics Board recommended in a report sent to the Senate Health, Education, Labor and Pensions Committee and the House Energy and Commerce Committee that Health and Human Services (HHS) Secretary Alex Azar only fund one of the proposals and withhold f...
Source: Public Policy Reports - September 15, 2020 Category: Biology Authors: AIBS Source Type: news

Brain scans may help predict response to OCD therapies
Differences in brain activity seen on scans taken before psychotherapy for obsessive-compulsive disorder corresponded with responses to treatment. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - September 15, 2020 Category: Consumer Health News Source Type: news

How high fructose intake may trigger fatty liver disease
A study suggested that consuming high amounts of fructose may promote non-alcoholic fatty liver disease by damaging the intestinal barrier. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - September 15, 2020 Category: Consumer Health News Source Type: news

NIH to fund PET imaging for Latino Alzheimer's study
The U.S. National Institutes of Health (NIH) has provided additional funding...Read more on AuntMinnie.comRelated Reading: MRI-trained CAD identifies cognitive impairment FDG levels show link between Alzheimer's, Down syndrome New tau PET tracer better targets source of Alzheimer's New PET technique visualizes early Alzheimer's disease PET tracer could more precisely diagnose Alzheimer's (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 14, 2020 Category: Radiology Source Type: news

Artificial pancreas helps children with type 1 diabetes
A new artificial pancreas system, which monitors and regulates blood glucose levels, proved safe and effective in young children with type 1 diabetes. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - September 14, 2020 Category: Consumer Health News Source Type: news

NIH augments large scale study of Alzheimer ’s disease biomarkers
HABLE study prioritizes brain imaging and biomarker research among Mexican Americans. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 14, 2020 Category: American Health Source Type: news

Tenure-track or tenure-eligible investigator in biomedical image processing
The National Library of Medicine (NLM), a component of the National Institutes of Health (NIH) and the Department of Health and Human Services (DHHS), is recruiting for a tenure-track or tenure-eligible investigator within its Intramural Research Program (IRP) in Bethesda, MD. The recruitment is part of a planned expansion of NLM ’s intramural research in computational health sciences. The goal of this search is to identify candidates with the potential to develop a dynamic, innovative, and independent research program with a focus on clinical image processing (e.g., radiology, pathology, endoscopy). (Source: NLM General Announcements)
Source: NLM General Announcements - September 14, 2020 Category: Databases & Libraries Source Type: news

Substance use disorders linked to COVID-19 susceptibility
NIH research finds higher risk and worse outcomes for those with addiction. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 14, 2020 Category: American Health Source Type: news

Children's Hospital Los Angeles is US site for $7M study of COVID-19 transmission
(Children's Hospital Los Angeles) Researchers at The Saban Research Institute of Children's Hospital Los Angeles, as well as in Nicaragua and New Zealand, are enrolling 250-325 households in a new study designed to study how COVID-19 spreads within households. The study was awarded $7.1 million by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2020 Category: International Medicine & Public Health Source Type: news

Gentle probes could enable massive brain data collection
(Rice University) The National Institutes of Health is backing a Rice University project to continue the development of flexible nanoelectronic thread to gather information from neurons. The miniaturized implants could ultimately help find therapies for neurological disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2020 Category: International Medicine & Public Health Source Type: news

Substance use disorders linked to COVID-19 susceptibility
(NIH/National Institute on Drug Abuse) A National Institutes of Health-funded study found that people with substance use disorders (SUDs) are more susceptible to COVID-19 and its complications. The research, published today in Molecular Psychiatry, was co-authored by Nora D. Volkow, M.D., director of the National Institute on Drug Abuse (NIDA). The findings suggest that health care providers should closely monitor patients with SUDs and develop action plans to help shield them from infection and severe outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2020 Category: International Medicine & Public Health Source Type: news

Trump Pressed for Plasma Therapy. Officials Worry, Is an Unvetted Vaccine Next?
New details of how the president has demanded faster action from health agencies help explain the intensifying concern that he could demand pre-Election Day approval of a vaccine. (Source: NYT Health)
Source: NYT Health - September 13, 2020 Category: Consumer Health News Authors: Sharon LaFraniere, Noah Weiland and Michael D. Shear Tags: Coronavirus (2019-nCoV) Trump, Donald J National Institutes of Health Food and Drug Administration United States Politics and Government Presidential Election of 2020 Republican National Convention Collins, Francis S Marks, Peter Hahn, S Source Type: news

Africa: Know the Beginning Well - an Inside Journey Through Five Decades of African Development
[Africa Renewal] In 1977, a thirty-three-year-old Ghanaian economist with the World Bank was diagnosed with a rare blood disorder that confounded doctors in a hospital in Alexandria, Virginia, United States. One day, his heart almost stopped as he passed out. He was later transferred to the National Institute of Health (NIH) in Washington, D.C. where another team of doctors successfully treated him. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 12, 2020 Category: African Health Source Type: news

NIH Launches Two Trials to Test Blood Thinners in COVID-19 Patients NIH Launches Two Trials to Test Blood Thinners in COVID-19 Patients
The National Institutes of Health said on Thursday it has launched two of the three late-stage clinical trials to test the effectiveness and safety of different types of blood thinners in treating COVID-19 among adults.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

---
CNN's Anderson Cooper and Dr. Sanjay Gupta talk to National Institutes of Health Director Dr. Francis Collins about the ongoing vaccine trials for Covid-19. (Source: CNN.com - Health)
Source: CNN.com - Health - September 11, 2020 Category: Consumer Health News Source Type: news

Taking a closer look at the genome
(University of Miami) Zheng Wang, a University of Miami computer scientist who specializes in bioinformatics research, recently received a five-year, $1.82 million Maximizing Investigators' Research Award (MIRA), considered one of the most prestigious National Institutes of Health awards for outstanding investigators, to develop more complex computational algorithms that will enable closer looks at the 3D genome. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 11, 2020 Category: Biology Source Type: news

Staff scientist 1, sequence analysis pipelines
CLOSING DATE: October 9, 2020: POSITION INFORMATION SUMMARY: The National Library of Medicine ’s (NLM), National Center for Biotechnology Information (NCBI) is recruiting for a Staff Scientist 1. The position is in the Information Engineering Branch (IEB) and supports bioinformatics algorithm development for the genome assembly, annotation, and analysis pipelines. NLM is one of the 27 Inst itutes at the National Institutes of Health (NIH) part of the Department of Health and Human Services (DHHS). (Source: NLM General Announcements)
Source: NLM General Announcements - September 10, 2020 Category: Databases & Libraries Source Type: news

The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

GTEx Consortium releases fresh insights into how DNA differences govern gene expression
(Broad Institute of MIT and Harvard) Scientists from the Genotype-Tissue Expression (GTEx) project, a National Institutes of Health-funded consortium, have completed a wide-ranging set of studies documenting how small changes in DNA sequence can impact gene expression across more than four dozen tissues in the human body. These studies, released in a set of 15 papers published in Science and other journals, constitute the most comprehensive catalog to date of genetic variations that affect gene expression. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 10, 2020 Category: Biology Source Type: news

NIH launches adaptive clinical trials of blood clotting treatments for COVID-19
(NIH/Office of the Director) The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the ACTIV initiative, these trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings -- those who have not been hospitalized, those currently hospitalized and those discharged after hospitalization for moderate to severe disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 10, 2020 Category: Infectious Diseases Source Type: news

Halt of coronavirus trial is 'safety valve' at work: Fauci
The National Institutes of Health director is telling Congress that AstraZeneca's suspension of its COVID-19 vaccine study shows there will be “no compromises” on safety in developing the shots (Source: ABC News: Health)
Source: ABC News: Health - September 10, 2020 Category: Consumer Health News Tags: Health Source Type: news

Surgeon General and NIH director pledge to get Covid-19 vaccine in public once approved
Dr. Francis Collins, director of the National Institutes of Health, and Dr. Jerome Adams, US Surgeon General, pledged in a Senate hearing Wednesday they would get the Covid-19 vaccine if and when one is deemed safe. (Source: CNN.com - Health)
Source: CNN.com - Health - September 9, 2020 Category: Consumer Health News Source Type: news

Probiotic skin therapy improves eczema in children, NIH study suggests
Experimental treatment to modify the skin microbiome may offer long-term benefits. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 9, 2020 Category: American Health Source Type: news

NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19
The trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 9, 2020 Category: American Health Source Type: news

Study shows decline in awareness, treatment and control of high blood pressure
The trend could threaten decades of public health work against heart disease. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 9, 2020 Category: American Health Source Type: news

Why COVID-19 Vaccines Need to Prioritize ‘ Superspreaders ’
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Why COVID-19 Vaccines Need to Prioritize ‘Superspreaders’ appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - September 9, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health COVID-19 Source Type: news

Miglustat improves swallowing in children and adolescents with Niemann-Pick type C1 disease
NIH observational study suggests that the drug may decrease risk of pneumonia and death in this population. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 9, 2020 Category: American Health Source Type: news

New ads encourage minorities to roll up their sleeves and participate in coronavirus vaccine trials
A group funded by the National Institutes of Health has released a series of emotional television ads asking Black people and Latinos to roll up their sleeves and become study participants in clinical trials for coronavirus vaccines. (Source: CNN.com - Health)
Source: CNN.com - Health - September 8, 2020 Category: Consumer Health News Source Type: news

US NIH Awards Nine Companies $129 Mln to Scale Up COVID-19 Testing US NIH Awards Nine Companies $129 Mln to Scale Up COVID-19 Testing
The National Institutes of Health is awarding $129.3 million to nine companies to support scaling-up coronavirus testing and manufacturing new testing technologies, the U.S. health agency said on Wednesday.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 3, 2020 Category: Pathology Tags: Infectious Diseases News Source Type: news

Backed by Federal Funds, New Virus Tests Are Hitting the Market
Six months into the pandemic and with no coherent national testing strategy, the Trump administration is encouraging private development of an array of faster and cheaper techniques. (Source: NYT Health)
Source: NYT Health - September 3, 2020 Category: Consumer Health News Authors: Sharon LaFraniere and Katherine J. Wu Tags: Coronavirus (2019-nCoV) Tests (Medical) United States Politics and Government Trump, Donald J Giroir, Brett P Budgets and Budgeting Regulation and Deregulation of Industry National Institutes of Health Food and Drug Administration Health Source Type: news

No Proof Convalescent Plasma Effective Against COVID-19
WEDNESDAY, Sept. 2, 2020 -- There is no evidence to support the use of convalescent plasma to treat COVID-19 patients, and doctors should not consider it a standard of care until more research is completed, a U.S. National Institutes of Health... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 2, 2020 Category: Pharmaceuticals Source Type: news

NIH continues to boost national COVID-19 testing capacity
New laboratory and point-of-care tests to enable access and rapid result. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 2, 2020 Category: American Health Source Type: news

Gene therapy research for HIV awarded $14.6 million NIH grant
(Keck School of Medicine of USC) An HIV research program led by scientists at USC and the Fred Hutchinson Cancer Research Center has received a five-year, $14.6 million grant from the National Institutes of Health. The team is advancing a gene therapy approach to control the virus without the need for daily medicines. The NIH award will support preclinical studies that combine gene editing against HIV with technologies for safer and more effective hematopoietic stem cell transplants. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 2, 2020 Category: Infectious Diseases Source Type: news

US health agency experts cast doubt on plasma for Covid-19
National Institutes of Health panel says ‘insufficient’ evidence to back treatment touted by Trump (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 2, 2020 Category: Pharmaceuticals Source Type: news

Plasma should not be considered standard care for coronavirus, NIH panel says
A National Institutes of Health panel said there's no evidence backing the use of convalescent plasma to treat coronavirus patients and that doctors should not treat it as a standard of care until more study has been done. (Source: CNN.com - Health)
Source: CNN.com - Health - September 2, 2020 Category: Consumer Health News Source Type: news